The second largest country in the world, India, has become a hotbed
of pharmaceutical fraud, as unscrupulous drug companies, mostly from the
West, continue to use India's generally poorer populations as human
guinea pigs in unethical and flat-out inhumane clinical trials.
And India's Supreme Court is finally taking action against this massive organized crime ring by ordering India's health ministry to justify its approval of 162 global clinical trials to take place in the country.
Because it is a rapidly developing nation with lax regulatory protocols, India has been a primary target of the pharmaceutical cartel in its never-ending quest to dominate the medical systems of the world. Major drug companies have been largely successful in swindling the Indian government to approve trials for all sorts of "new chemical entities" (NCEs), many of which have been tested on rural Indians in poorer communities, where there is minimal access to proper medical care.